License Agreements
9,590 Contracts & Agreements
License agreements define rights and other benefits for the licensing of intellectual property.
Browse License Agreements by Industry
- Aerospace & Defense (21 contracts from 9 companies)
- Air Freight & Logistics (7 | 3)
- Airlines (4 | 2)
- Auto Components (9 | 8)
- Automobiles (7 | 5)
- Banks (10 | 8)
- Beverages (11 | 3)
- Biotechnology (2,932 | 521)
- Building Products (8 | 5)
- Capital Markets (185 | 18)
- Chemicals (71 | 23)
- Commercial Services & Supplies (39 | 18)
- Communications Equipment (21 | 15)
- Construction & Engineering (7 | 2)
- Consumer Finance (8 | 6)
- Containers & Packaging (7 | 2)
- Distributors (3 | 2)
- Diversified Consumer Services (24 | 6)
- Diversified Financial Services (8 | 6)
- Diversified Telecommunication Services (8 | 6)
- Electric Utilities (10 | 5)
- Electrical Equipment (32 | 12)
- Electronic Equipment, Instruments & Components (41 | 18)
- Energy Equipment & Services (74 | 39)
- Entertainment (70 | 13)
- Equity Real Estate Investment Trusts (REITs) (12 | 7)
- ETFs (87 | 49)
- Food Products (48 | 20)
- Food & Staples Retailing (5 | 3)
- Gas Utilities (1 | 1)
- Health Care Equipment & Supplies (647 | 176)
- Health Care Providers & Services (210 | 77)
- Health Care Technology (30 | 16)
- Hotels, Restaurants & Leisure (77 | 34)
- Household Durables (35 | 12)
- Household Products (1 | 1)
- Independent Power & Renewable Electricity Producers (1 | 1)
- Industrial Conglomerates (3 | 2)
- Insurance (8 | 8)
- Interactive Media & Services (28 | 17)
- Internet & Direct Marketing Retail (16 | 10)
- IT Services (37 | 15)
- Leisure Products (11 | 7)
- Life Sciences Tools & Services (163 | 26)
- Machinery (13 | 9)
- Media (67 | 17)
- Metals & Mining (44 | 17)
- Multiline Retail (1 | 1)
- Oil, Gas & Consumable Fuels (82 | 31)
- Paper & Forest Products (4 | 1)
- Personal Products (61 | 24)
- Pharmaceuticals (1,226 | 271)
- Professional Services (17 | 10)
- Real Estate Management & Development (4 | 3)
- Semiconductors & Semiconductor Equipment (91 | 34)
- Software (200 | 58)
- SPACs, Investment, & Acquisition Companies (124 | 47)
- Specialty Retail (14 | 9)
- Technology Hardware, Storage & Peripherals (26 | 10)
- Textiles, Apparel & Luxury Goods (52 | 12)
- Thrifts & Mortgage Finance (2 | 1)
- Tobacco (8 | 2)
- Trading Companies & Distributors (1 | 1)
- Transportation Infrastructure (1 | 1)
- Water Utilities (4 | 3)
- Wireless Telecommunication Services (10 | 4)
- Unassigned Industry (2,504 | 968)
- Amendment to License Agreement with the Trailer Park Boys 9/24/2024 (Functional Brands Inc., Filed With SEC on January 8, 2025)
- Amendment to the License Agreement, dated August 16, 2023, between Trailer Park Boys Incorporated and Hemptown Organics Corp (Functional Brands Inc., Filed With SEC on January 8, 2025)
- License Agreement, dated July 7, 2021, between Trailer Park Boys Incorporated and Hemptown Organics Corp (Functional Brands Inc., Filed With SEC on January 8, 2025)
- Exclusive License Agreement, dated as of November 21, 2022, by and between Theodore R. Anderson and Rain Enhancement Technologies, Inc (Rain Enhancement Technologies Holdco, Inc., Filed With SEC on January 7, 2025)
- License Agreement, dated as of March 27, 2024, by and between Maze Therapeutics, Inc. and Shionogi & Co., Ltd (Maze Therapeutics, Inc., Filed With SEC on January 7, 2025)
- Fourth Amendment to Data License Agreement, dated as of December 31, 2024, by and between comScore, Inc. and Charter Communications Operating, LLC (COMSCORE, INC., Filed With SEC on January 7, 2025)
- Control Algorithm License Agreement, dated December 23, 2015, by and between Trustees of Boston University and the Registrant, as amended by the First Amendment dated December 11,... (Beta Bionics, Inc, Filed With SEC on January 6, 2025)
- Device License Agreement, dated December 16, 2015, by and between Trustees of Boston University and the Registrant, as amended by the First Amendment dated December 11, 2017, the... (Beta Bionics, Inc, Filed With SEC on January 6, 2025)
- Amended and Restated Exclusive License Agreement by and between University of Southern California, and NeOnc Technologies, Inc (NEONC TECHNOLOGIES HOLDINGS, INC., Filed With SEC on January 3, 2025)
- Exclusive License Agreement, dated December 31, 2024, by and between iBio, Inc. and AstralBio, Inc (iBio, Inc., Filed With SEC on January 2, 2025)
- Exclusive License Agreement, dated October 18, 2023, between Laser Photonics Corporation and Fonon Technologies, Inc (Laser Photonics Corp, Filed With SEC on December 31, 2024)
- IP License Agreement by and between Trina Solar Co., Ltd. and FREYR Battery, Inc., dated of December 23, 2024 (FREYR Battery, Inc., Filed With SEC on December 27, 2024)
- Seventh Amendment to Exclusive License Agreements (BROWN ID 2465, 2576, 2587, BROWN ID 3039, BROWN ID 2613, BROWN ID 2502) between Elkurt Inc. and Ocean Biomedical, Inc. (n/k/a... (Aesther Healthcare Acquisition Corp., Filed With SEC on December 23, 2024)
- Seventh Amendment to Exclusive License Agreements (BROWN ID 2465, 2576, 2587, BROWN ID 3039, BROWN ID 2613, BROWN ID 2502) between Elkurt Inc. and Ocean Biomedical, Inc. (n/k/a... (Aesther Healthcare Acquisition Corp., Filed With SEC on December 23, 2024)
- LICENSE AGREEMENT by and between Shanghai Jemincare Pharmaceutical Co., Ltd. and RAPT Therapeutics, Inc. dated as of December 22, 2024 (RAPT Therapeutics, Inc., Filed With SEC on December 23, 2024)
- Exclusive License Agreement by and between the StemMed, Ltd. and Baylor College of Medicine, dated June 19, 2015, subject to Notice of Assignment from Stem Med Limited Partnership... (Cara Therapeutics, Inc., Filed With SEC on December 18, 2024)
- Exclusive License Agreement by and between the StemMed, Ltd. (f/k/a Stem Med Limited Partnership) and Baylor College of Medicine, dated July 16, 2012, as amended April 26, 2015,... (Cara Therapeutics, Inc., Filed With SEC on December 18, 2024)
- Amendment #1 to License Agreement by and between the Company and Akebia Therapeutics, Inc. dated December 13, 2024 (Cyclerion Therapeutics, Inc., Filed With SEC on December 17, 2024)
- Amendment to License Agreement between the BC Cancer Agency, UBC and the Company, dated May 25, 2021 (Schedules have been omitted pursuant to Item 601(b)(10) of Regulation S-K.... (ESSA Pharma Inc., Filed With SEC on December 17, 2024)
- License Agreement, dated December 20, 2023 between Yissum Research Development Company of the Hebrew University of Jerusalem, Ltd, University of Rijeka Faculty of Medicine, and... (INVO Bioscience, Inc., Filed With SEC on December 17, 2024)
- License Agreement, dated December 19, 2023, between Inserm Transfert, Cytovia Therapeutics, Inc., and NAYA Therapeutics, Inc (fka NAYA Biosciences, Inc (INVO Bioscience, Inc., Filed With SEC on December 17, 2024)
- License & Management Agreement, dated December 14, 2024, by and between (Mountain Crest Acquisition Corp., Filed With SEC on December 16, 2024)
- License Agreement, dated as of April 8, 2021, by and between Kalaris Therapeutics, Inc. (formerly Theia Therapeutics, Inc.) and the Regents of the University of California, as... (Allovir, Inc., Filed With SEC on December 9, 2024)
- Form of Exclusive Source Code License agreement (True Nature Holding, Inc., Filed With SEC on December 6, 2024)
- Amendment to Amended and Restated Distribution License and Marketing Services Agreement, dated September 30, 2024, by and between the 5&2 Studios, Inc. and Come and See... (Chosen, Inc., Filed With SEC on December 6, 2024)
- Extension letter, dated October 16, 2024, extending the term of the January 1, 2020, License Agreement among Tommy Hilfiger Licensing LLC, Movado Group, Inc. and Swissam Products... (Movado Group, Inc., Filed With SEC on December 5, 2024)
- First Amendment dated September 17, 2024, to the Amended and Restated License Agreement dated March 17, 2022, between the Company and HUGO BOSS AG Branch CH-Zug (Movado Group, Inc., Filed With SEC on December 5, 2024)
- Fifth Amendment dated September 12, 2024, to the Amended and Restated License Agreement dated January 13, 2015, between the Company and Tapestry, Inc (Movado Group, Inc., Filed With SEC on December 5, 2024)
- Fourth Amendment dated August 31, 2023, to the Amended and Restated License Agreement dated January 13, 2015, between the Company and Tapestry, Inc (Movado Group, Inc., Filed With SEC on December 5, 2024)
- Third Amendment dated February 2, 2023, to the Amended and Restated License Agreement dated January 13, 2015, between the Company and Tapestry, Inc (Movado Group, Inc., Filed With SEC on December 5, 2024)
- Brand License Agreement, dated as of December 2, 2024, by and between TechTarget, Inc. (formerly known as Toro CombineCo, Inc.) and Informa Group Limited (Toro CombineCo, Inc., Filed With SEC on December 3, 2024)
- Cell Line License Agreement, effective October 22, 2024, by and between WuXi Biologics Ireland Limited and Jade Biosciences, Inc (Aerovate Therapeutics, Inc., Filed With SEC on December 3, 2024)
- APRIL License Agreement, dated October 30, 2024, by and between Paragon Therapeutics, Inc. and Jade Biosciences, Inc (Aerovate Therapeutics, Inc., Filed With SEC on December 3, 2024)
- Amendment No. 1 to Second Amended and Restated Supply and License Agreement, dated March 5, 2024, between 4C Medical Technologies, Inc. and Anteris Technologies Corporation (Anteris Technologies Global Corp., Filed With SEC on November 22, 2024)
- Second Amended and Restated Supply and License Agreement, dated June 1, 2018, between 4C Medical Technologies, Inc. and Admedus Corporation (Anteris Technologies Global Corp., Filed With SEC on November 22, 2024)
- License Agreement, dated October 11, 2019, among Admedus Ltd, Admedus Regen Pty Ltd, Admedus Biomanufacturing Pty Ltd and LeMaitre Vascular, Inc (Anteris Technologies Global Corp., Filed With SEC on November 22, 2024)
- Amendment to License Agreement with Monarch Media (Blue Line Holdings, Inc., Filed With SEC on November 19, 2024)
- License Agreement with Monarch Media, LLC (Blue Line Holdings, Inc., Filed With SEC on November 19, 2024)
- Amendment to License Agreement (Comstock Mining Inc., Filed With SEC on November 19, 2024)
- Nonexclusive License Agreement between Neurogene Inc. and the Board of Trustees of the Leland Stanford Junior University dated August 6, 2024 (AQUINOX PHARMACEUTICALS, INC, Filed With SEC on November 18, 2024)
